| Literature DB >> 35246181 |
Ya-Fu Cheng1, Yueh-Che Hsieh2, Yu-Jun Chang3, Ching-Yuan Cheng1, Chang-Lun Huang1, Wei-Heng Hung1, Bing-Yen Wang4,5,6,7,8,9.
Abstract
BACKGROUND: For stage I non-small cell lung cancer (NSCLC), lobectomy and segmentectomy are still controversial operations. Extended segmentectomy was proposed to make larger safe margins than segmentectomy. Image-guided video-assisted thoracoscopic surgery (iVATS) is useful to accomplish extended segmentectomy. We aimed to compare the effects of iVATS extended segmentectomy to the effects of traditional segmentectomy for stage I NSCLC.Entities:
Keywords: Extended segmentectomy; Image-guided video-assisted thoracoscopic surgery (iVATS); Non-small cell lung cancer (NSCLC); Resection margin
Mesh:
Year: 2022 PMID: 35246181 PMCID: PMC8895589 DOI: 10.1186/s13019-022-01771-4
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1The nodule site and margin during an iVATS extended segmentectomy
Fig. 2Patient enrollment process
Clinical demographic data of patients
| iVATS extended (n = 62) | Traditional (n = 54) | |||||
|---|---|---|---|---|---|---|
| N | % | N | % | |||
| Gender | Male | 26 | 41.9 | 20 | 37.0 | 0.591 |
| Female | 36 | 58.1 | 34 | 63.0 | ||
| Age | Median (IQR) | 58.0 | (52.0–64.0) | 59.5 | (54.0–67.0) | 0.232 |
| Tumor location | Right upper lobe | 28 | 45.2 | 14 | 25.9 | 0.049 |
| Right middle lobe | 1 | 1.6 | 1 | 1.9 | ||
| Right lower lobe | 10 | 16.1 | 10 | 18.5 | ||
| Left upper lobe | 18 | 29.0 | 15 | 27.8 | ||
| Left lower lobe | 5 | 8.1 | 14 | 25.9 | ||
| FEV1 (%) | Median (IQR) | 93.1 | (86.1–105.0) | 89.4 | (79.5–97.3) | 0.050 |
| Differentiation | Well | 22 | 35.5 | 13 | 24.5 | 0.308 |
| Moderately | 39 | 62.9 | 37 | 69.8 | ||
| Poor | 1 | 1.6 | 3 | 5.7 | ||
| Histology | Adenocarcinoma | 62 | 100.0 | 49 | 90.7 | 0.020 |
| Squamous cell carcinoma | 0 | 0.0 | 3 | 5.6 | ||
| Others | 0 | 0.0 | 2 | 3.7 | ||
| Pathologic T stage | Tis | 12 | 19.4 | 5 | 9.3 | 0.076 |
| Tmi | 14 | 22.6 | 7 | 13.0 | ||
| T1 | 36 | 58.1 | 42 | 77.8 | ||
| Subtype | Lepidic | 26 | 41.9 | 18 | 34.6 | 0.424 |
| Non-lepidic | 36 | 58.1 | 34 | 65.4 | ||
| STAS | No | 57 | 91.9 | 48 | 88.9 | 0.576 |
| Yes | 5 | 8.1 | 6 | 11.1 | ||
| Pleural invasion | No | 60 | 96.8 | 50 | 92.6 | 0.415 |
| Yes | 2 | 3.2 | 4 | 7.4 | ||
| Lymph invasion | No | 61 | 98.4 | 48 | 88.9 | 0.049 |
| Yes | 1 | 1.6 | 6 | 11.1 | ||
| Enough margin | No | 15 | 24.2 | 23 | 42.6 | 0.035 |
| Yes | 47 | 75.8 | 31 | 57.4 | ||
FEV1, forced expiratory volume in one second; STAS, spread through air spaces; Lymph invasion, lymphovascular invasion; IQR, interquartile range between the 25th percentile and the 75th percentile
Outcomes of traditional segmentectomy and iVATS extended segmentectomy
| iVATS extended segmentectomy (n = 62) | Traditional segmentectomy (n = 54) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | Mean | SD | Median | Q1 | Q3 | Mean | SD | Median | Q1 | Q3 | |
| OP time (min) | 109.1 | 20.3 | 106.0 | 94.0 | 123.0 | 112.8 | 18.9 | 108.0 | 98.0 | 127.0 | 0.259 |
| Blood loss (ml) | 60.1 | 55.0 | 50.0 | 20.0 | 50.0 | 65.9 | 64.9 | 50.0 | 20.0 | 100.0 | 0.871 |
| Nodule size (mm) | 10.3 | 4.1 | 10.0 | 7.0 | 13.0 | 11.6 | 4.1 | 11.5 | 8.0 | 15.0 | 0.071 |
| Distance to the pleura (mm) | 5.8 | 6.1 | 3.0 | 1.0 | 10.0 | 4.7 | 4.8 | 3.0 | 1.0 | 6.0 | 0.556 |
| Closest to staple line (mm) | 17.9 | 9.3 | 15.0 | 10.0 | 25.0 | 14.1 | 8.8 | 12.0 | 8.0 | 20.0 | 0.037 |
| Margin/tumor ratio | 2.1 | 1.4 | 1.9 | 1.0 | 2.8 | 1.4 | 1.0 | 1.2 | 0.6 | 2.0 | 0.003 |
Q1 = percentile 25; Q3 = percentile 75; P-value by Mann–Whitney U Test
Results of resected segment distribution
| iVATS extended (n = 62) | Traditional (n = 54) | |||||
|---|---|---|---|---|---|---|
| N | % | N | % | |||
| Tumor location | RS1 | 12 | 19.4 | 7 | 13.0 | 0.003 |
| RS2 | 10 | 16.1 | 4 | 7.4 | ||
| RS3 | 6 | 9.7 | 3 | 5.6 | ||
| RS5 | 1 | 1.6 | 1 | 1.9 | ||
| RS6 | 7 | 11.3 | 8 | 14.8 | ||
| RS7+8 | 1 | 1.6 | 0 | 0 | ||
| RS9+10 | 2 | 3.2 | 2 | 3.7 | ||
LS1+2 LS | 10 | 16.1 | 9 | 16.7 | ||
| LS3 | 5 | 8.1 | 4 | 7.4 | ||
| LS4+5 | 3 | 4.8 | 2 | 3.7 | ||
| LS6 | 4 | 6.4 | 11 | 20.4 | ||
| LS8 | 0 | 0 | 1 | 1.9 | ||
| LS9+10 | 1 | 1.6 | 2 | 3.7 | ||
Fig. 3Subgroup analysis of iVATS extended segmentectomy, the T1a lesions had larger margin distances than did T1b lesions (19.85 mm vs. 14.83 mm, p = 0.026)
Results of generalized linear model on resection margin
| Parameter | Bivariable analysis (crude) | Multivariable analysis (adjusted) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| β | SE | 95% CI | β | SE | 95% CI | ||||
| Surgical type | iVATS extended segmentectomy | 3.787 | 1.670 | 0.514 to 7.061 | 0.023 | 4.636 | 1.647 | 1.408 to 7.865 | 0.005 |
| Traditional segmentectomy (ref) | 0.000 | 0.000 | |||||||
| Age | 0.055 | 0.086 | − 0.113 to 0.223 | 0.522 | 0.169 | 0.084 | 0.005 to 0.333 | 0.043 | |
| Location | Left lower lobe | 2.994 | 2.485 | − 1.877 to 7.865 | 0.228 | 6.132 | 2.399 | 1.431 to 10.833 | 0.011 |
| Left upper lobe | 1.552 | 2.091 | − 2.546 to 5.650 | 0.458 | 3.299 | 1.961 | − 0.545 to 7.143 | 0.093 | |
| Right lower lobe | 3.860 | 2.442 | − 0.927 to 8.646 | 0.114 | 5.568 | 2.307 | 1.047 to 10.090 | 0.016 | |
| Right middle lobe | − 6.690 | 6.505 | − 19.441 to 6.060 | 0.304 | − 6.261 | 5.948 | − 17.919 to 5.398 | 0.293 | |
| Right upper lobe (ref) | 0.000 | 0.000 | |||||||
| FEV1 | 0.037 | 0.052 | − 0.065 to 0.138 | 0.481 | |||||
| Histology | Others | − 14.541 | 6.383 | − 27.051 to − 2.030 | 0.023 | − 20.697 | 6.923 | − 34.267 to − 7.128 | 0.003 |
| Squamous cell carcinoma | − 4.541 | 5.235 | − 14.801 to 5.720 | 0.386 | − 7.456 | 5.090 | − 17.433 to 2.521 | 0.143 | |
| Adenocarcinoma (ref) | 0.000 | 0.000 | |||||||
| T stage | 1b | − 2.090 | 1.696 | − 5.413 to 1.234 | 0.218 | − 3.429 | 1.662 | − 6.687 to − 0.171 | 0.039 |
| 1a (ref) | 0.000 | 0.000 | |||||||
| Lymph invasion | Yes | 0.121 | 3.576 | − 6.887 to 7.128 | 0.973 | 7.977 | 3.982 | 0.173 to 15.782 | 0.045 |
| No (ref) | 0.000 | 0.000 | |||||||
β, regression coefficient; CI, confidence interval; Lymph invasion, lymphovascular invasion